# Rates for HEDIS Screening for Diabetic Nephropathy Quality Measure May Be Overstated.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rates-for-hedis-screening-for-diabetic-nephropathy-quality-measure-may-be/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Trudy Millard Krause,Cecilia Ganduglia‐Cazaban,Kevin W. Finkel |
| Citations | 6 |
| Fields | Economics, Econometrics and Finance,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3025659081 |
| PMID | 30142069 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Cecilia Ganduglia‐Cazaban](https://scholariq.org/researchers/cecilia-ganduglia-cazaban/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Clinical practice guidelines implementation](https://scholariq.org/topics/clinical-practice-guidelines-implementation/)

## Paper topics

- [Clinical practice guidelines implementation](https://scholariq.org/topics/clinical-practice-guidelines-implementation/)
- [Pharmaceutical industry and healthcare](https://scholariq.org/topics/pharmaceutical-industry-and-healthcare/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.